Loading...
Thumbnail Image
Publication

Membrane-type matrix metalloproteinases: expression, roles in metastatic prostate cancer progression and opportunities for drug targeting

Falconer, Robert A.
Publication Date
2017-12
End of Embargo
Supervisor
Rights
© The Author(s) 2017. This is an open access article licensed under the terms of Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original author is credited and the new creations are licensed under the identical terms.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2017-10-26
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
The membrane-type matrix metalloproteinases (MT-MMPs), an important subgroup of the wider MMP family, demonstrate widespread expression in multiple tumor types, and play key roles in cancer growth, migration, invasion and metastasis. Despite a large body of published research, relatively little information exists regarding evidence for MT-MMP expression and function in metastatic prostate cancer. This review provides an appraisal of the literature describing gene and protein expression in prostate cancer cells and clinical tissue, summarises the evidence for roles in prostate cancer progression, and examines the data relating to MT-MMP function in the development of bone metastases. Finally, the therapeutic potential of targeting MT-MMPs is considered. While MT-MMP inhibition presents a significant challenge, utilisation of MT-MMP expression and proteolytic capacity in prostate tumors is an attractive drug development opportunity.
Version
Published version
Citation
Falconer RA and Loadman PM (2017) Membrane-type matrix metalloproteinases: expression, roles in metastatic prostate cancer progression and opportunities for drug targeting. Journal of Cancer Metastasis and Treatment. 3: 315-327.
Link to publisher’s version
Link to published version
Type
Article
Qualification name
Notes